Mobile app support for breast surgery patients
Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients
This study is testing a mobile app called JEEVA to see if it can help breast surgery patients by providing useful information and support during their surgical experience.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05290402 on ClinicalTrials.gov |
What this trial studies
This research aims to evaluate the accessibility and usability of a mobile application called JEEVA for patients undergoing breast surgery. The study focuses on providing perioperative resources and support in a multimedia format to enhance patient experience during the surgical process. It will measure the ease of use and satisfaction with the app through a standardized usability questionnaire. The study is observational and will involve patients at the Texas Medical Center campus and surrounding locations.
Who should consider this trial
Good fit: Ideal candidates are breast surgical patients aged 18 and older who are evaluated at the Texas Medical Center campus or Houston Area Locations.
Not a fit: Patients without smartphones, those with visual impairments, cognitive impairments, or who do not have an in-person pre-operative visit will not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve the support and resources available to breast surgery patients during their perioperative period.
How similar studies have performed: Other studies have shown success with mobile health applications in improving patient engagement and satisfaction, suggesting a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects eligible for this study include breast surgical patients 18 years of age and older evaluated at the Texas Medical Center campus in the Nellie B Connally breast center or in the Houston Area Locations (HALs). This includes patients undergoing excisional biopsy, segmental mastectomy, total mastectomy, skin-sparing mastectomy, nipple-sparing mastectomy, sentinel lymphadenectomy, targeted axillary lymphadenectomy, axillary lymphadenectomy, and axillary reverse mapping. Exclusion Criteria: Patients who do not have a smartphone), which utilizes iOS or Android operating systems, Patients who have visual impairment or blindness, which precludes effective utilization of an app, will be excluded. Patients whose surgical planning is discussed by telephone outside of an in-person pre-operative visit, will be excluded from the study. Patients who have cognitive impairment will be exclude
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Christina Checka, MD — M.D. Anderson Cancer Center
- Study coordinator: Jaime Crow
- Email: jrcrow@mdanderson.org
- Phone: 713-792-6443
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.